Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

HPAI vaccine trials begin in the UK
Turkeys have been selected dur to their high susceptibility to HPAI.
Trials will focus on turkeys in England.

The Department for Environment, Food and Rural Affairs (Defra) has today (5 March) launched a targeted vaccine trial on turkeys in England.

The new trials will explore how these vaccines could be used as an additional tool to control highly pathogenic avian influenza (HPAI).

Researchers will study whether these vaccines can be used to protect birds, with a specific focus on turkeys in England. The trial is expected to provide insight into how these vaccines work in the field and manage the disease, contributing to a growing international body of HPAI vaccination research.

The project will also examine the use of surveillance to retain the trade of turkeys.

Researchers have selected turkeys as the priority species for this study due to their high susceptibility to avian influenza. Outbreaks among turkeys will result in severe clinical signs, including rapid mortality rates.

With approval from the Veterinary Medicines Directorate (VMD), the trial will sample a small group of birds under strict supervision using UK/EU authorised vaccines. The trial will last for 24 weeks.

Defra reports an ‘unprecedented’ amount of avian influenza outbreaks in both the UK and in Europe over the past few years. The diseases has impacted both captive and wild birds globally since 2020, which Defra says has caused ‘devastation’ to birdkeepers on the frontline and in the poultry sector.

Christine Middlemiss, chief veterinary officer, said: “This targeted trial is going to be really key for our understanding of how HPAI vaccines can be effectively used for disease control in the UK. They have the potential to be a really valuable additional tool in helping us protect birds from infection.  
 
“Stringent biosecurity will always remain our best defence and [we] urge all bird keepers to continue to take the steps needed to prevent avian influenza spreading onto their premises.”

Baroness Hayman, biosecurity minister, said: “The start of new vaccine trials are a significant step forward in our fight against this disease and will contribute to global research efforts. We are hopeful vaccines can be used in the UK as an additional tool to control bird flu to protect the UK's biosecurity and food supply.”

Image © Shutterstock.com/Sergey kolesnikov

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.